Title Credit Typesort descending Event date Cost
Virtual Practice Managing Immune-Related Adverse Events (irAEs) in Simulated Scenarios
    • 0.50 AMA PRA Category 1 Credit™
 Enduring $0.00
Bispecific Therapy in Cancer Treatment
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Updates in Management of Advanced Renal Cell Carcinoma: Making Sense of the Menu
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Genetic Testing and Counseling in the Community Setting: Germline and Somatic
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Cancer-Associated Venous Thromboembolism: Anticoagulation Considerations and Controversies (On-Demand)
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 ANCC
 Enduring $0.00
Best Practices in the Diagnosis and Management of Homozygous Familial Hypercholesterolemia: Towards Individualized Treatment Strategies
    • 1.00 AMA PRA Category 1 Credit™
 Enduring $0.00
An Overview of Radiation Oncology for Health Care Providers (On-Demand)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC
 Enduring $0.00
Taking a Deep Breath: A Curriculum in Current and Emerging Strategies for Optimizing COPD Treatment
    • 1.25 AMA PRA Category 1 Credit™
 Enduring $0.00
Best Practices for Opioid Pain Management in Patients with Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Revolutionizing Leukemia Treatment: Allogeneic Transplants, Engineered T Cell Therapy, and Navigating the Complexities of GVHD
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Gynecologic Oncology: Pelvic Mass and Abnormal Bleeding
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Take Note! Charting Accuracy Improves Patient Outcomes and Keeps the Lights On – A Guide to Note-Taking For Solid Tumors (On-Demand)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC
 Enduring $0.00
Updates in Lymphoma
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Hitting the Target: Updates and Review in Genotype Directed Therapy for Non-Small Cell Lung Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Treating Cancer with Bispecific Antibodies: Current Status and Future Directions
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
 Enduring $0.00

Pages